ARCA biopharma, Inc.
ARCA Announces Receipt of NASDAQ Notice per NASDAQ Rule 5810b
Published in Lab Business Week, April 4th, 2010
ARCA biopharma, Inc. (NASDAQ: ABIO), a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, announced, as required by NASDAQ Marketplace Rule 5810(b), that on March 12, 2010, it received a notice from the NASDAQ Stock Market indicating that the Company's stockholders' equity as of December 31, 2009, did not meet the minimum requirement of $10,000,000 for continued listing as set forth in Continued Listing Standards for Primary Equity Securities Rule 5450(b). This notification does not affect the listing of the Company's common stock at this time.
Under NASDAQ Rules, the Company has 45 calendar days to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2010-04-04)
More Articles from Lab Business Week
- Abbott
New Data Demonstrates Abbott's Investigational MitraClip System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition - ALM
The National Law Journal Reports That Dollar Value of Top 100 Verdict Awards Rose Only 1 Percent in 2009 - Ataxia
Reports from Haskins Laboratories highlight recent research in ataxia - Atherosclerosis Vaccines
Scientists at Gorlaeus Laboratories report research in atherosclerosis vaccines - Autism Spectrum Disorders
A Better Genetic Test for Autism - Biotechnology Business
Mini-PROTEAN(R) TGX Gels Deliver Reproducible Laemmli PAGE Performance, Unprecedented Speed, and Extended Shelf Life - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
